Elixir spuds key well at its Mongolian CBM drilling program

|

Published 18-NOV-2019 09:52 A.M.

|

1 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

In an update on its 2019 drilling program at its 100% owned Nomgon IX coalbed methane (CBM) production sharing contract (PSC) in Mongolia, Elixir Energy Limited (ASX:EXR) report that it has spud its key well for 2019.

The program’s prime aim is the drilling of two fully tested core-holes — with an option for a third, the results of which will feed into a contingent resource assessment in the new year. These core-holes are targeting Elixir’s developed CSG leads, which were defined by surface outcrop, gravity and 2D seismic mapping.

Ugtaal-1 core-hole

The Ugtaal-1 core-hole spudded last Monday, November 11 2019 and as of Sunday 17 November it had reached a depth of 122 metres. So far it has intersected lithologies include conglomerates, carbonaceous mudstones and thin coal stringers.

Two rigs are being used and both have been winterized, while the desorption lab has been set up at Ugtaal-1.

The winterized Ugtaal-1 well site
The winterized Ugtaal-1 well site

Elixir note that all wells are being drilled under a turn-key contract such that the company is paying on a per metre basis, rather that per day.

Chip holes

Prior to the spud of the first core hole, Elixir’s drilling program started with low cost chip-holes with multiple calibration and exploration aims.

Analysis has now commenced on the encouraging findings from the BO-CH-1 chip-hole, which reached a total depth of 738 metres. The chip hole demonstrated gas in the system, coal seams of a thickness which are productive in Australia and natural fracturing which may support good permeability.

The BO-CH-2 chip-hole had reached 408 metres as at Sunday morning.

Elixir’s Managing Director, Mr Neil Young said, “With the spudding of the Ugtaal-1 core-hole we have now commenced our key well for 2019. We anticipate the well reaching the Permian section later this week after which we will start testing coal cores for their gas content.”



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X